nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2A6—Bupropion—obesity	0.097	0.13	CbGbCtD
Nevirapine—CYP2B6—Benzphetamine—obesity	0.0742	0.0995	CbGbCtD
Nevirapine—CYP2B6—Bupropion—obesity	0.0631	0.0846	CbGbCtD
Nevirapine—CYP1A2—Phentermine—obesity	0.0435	0.0583	CbGbCtD
Nevirapine—CYP1A2—Phenylpropanolamine—obesity	0.0415	0.0556	CbGbCtD
Nevirapine—CYP2C9—Phentermine—obesity	0.0392	0.0526	CbGbCtD
Nevirapine—CYP1A2—Bupropion—obesity	0.037	0.0496	CbGbCtD
Nevirapine—CYP3A5—Cimetidine—obesity	0.0365	0.0489	CbGbCtD
Nevirapine—CYP2D6—Phentermine—obesity	0.0359	0.0481	CbGbCtD
Nevirapine—CYP2C9—Bupropion—obesity	0.0334	0.0447	CbGbCtD
Nevirapine—CYP2D6—Bupropion—obesity	0.0305	0.0409	CbGbCtD
Nevirapine—CYP3A4—Sibutramine—obesity	0.0301	0.0403	CbGbCtD
Nevirapine—CYP2D6—Methamphetamine—obesity	0.0287	0.0384	CbGbCtD
Nevirapine—CYP1A2—Cimetidine—obesity	0.0272	0.0364	CbGbCtD
Nevirapine—CYP2C9—Cimetidine—obesity	0.0245	0.0328	CbGbCtD
Nevirapine—CYP3A4—Benzphetamine—obesity	0.0228	0.0306	CbGbCtD
Nevirapine—CYP2D6—Cimetidine—obesity	0.0224	0.03	CbGbCtD
Nevirapine—CYP3A4—Bupropion—obesity	0.0194	0.026	CbGbCtD
Nevirapine—CYP3A4—Orlistat—obesity	0.0158	0.0212	CbGbCtD
Nevirapine—CYP3A4—Cimetidine—obesity	0.0142	0.0191	CbGbCtD
Nevirapine—CYP3A4—Topiramate—obesity	0.00932	0.0125	CbGbCtD
Nevirapine—Hypersensitivity—Benzphetamine—obesity	0.000738	0.00446	CcSEcCtD
Nevirapine—Rash maculo-papular—Bupropion—obesity	0.000733	0.00443	CcSEcCtD
Nevirapine—Mouth ulceration—Bupropion—obesity	0.000729	0.0044	CcSEcCtD
Nevirapine—Dermatitis bullous—Orlistat—obesity	0.000726	0.00439	CcSEcCtD
Nevirapine—Abdominal pain—Phendimetrazine—obesity	0.000722	0.00436	CcSEcCtD
Nevirapine—Malaise—Diethylpropion—obesity	0.000717	0.00433	CcSEcCtD
Nevirapine—Diarrhoea—Methamphetamine—obesity	0.000711	0.00429	CcSEcCtD
Nevirapine—Dermatitis bullous—Sibutramine—obesity	0.000703	0.00424	CcSEcCtD
Nevirapine—Somnolence—Phenylpropanolamine—obesity	0.000693	0.00419	CcSEcCtD
Nevirapine—Lymphadenopathy—Bupropion—obesity	0.000686	0.00414	CcSEcCtD
Nevirapine—Diarrhoea—Benzphetamine—obesity	0.000685	0.00414	CcSEcCtD
Nevirapine—Malaise—Cimetidine—obesity	0.000682	0.00412	CcSEcCtD
Nevirapine—Myalgia—Diethylpropion—obesity	0.000677	0.00409	CcSEcCtD
Nevirapine—Rash erythematous—Topiramate—obesity	0.000671	0.00405	CcSEcCtD
Nevirapine—Discomfort—Diethylpropion—obesity	0.000669	0.00404	CcSEcCtD
Nevirapine—Headache—Methamphetamine—obesity	0.000651	0.00393	CcSEcCtD
Nevirapine—Face oedema—Sibutramine—obesity	0.000648	0.00392	CcSEcCtD
Nevirapine—Arthralgia—Cimetidine—obesity	0.000644	0.00389	CcSEcCtD
Nevirapine—Myalgia—Cimetidine—obesity	0.000644	0.00389	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Phentermine—obesity	0.000644	0.00389	CcSEcCtD
Nevirapine—Fatigue—Phentermine—obesity	0.000643	0.00389	CcSEcCtD
Nevirapine—Feeling abnormal—Phenylpropanolamine—obesity	0.000643	0.00388	CcSEcCtD
Nevirapine—Headache—Benzphetamine—obesity	0.000627	0.00379	CcSEcCtD
Nevirapine—Diarrhoea—Phendimetrazine—obesity	0.000625	0.00377	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Topiramate—obesity	0.000624	0.00377	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Bupropion—obesity	0.00062	0.00375	CcSEcCtD
Nevirapine—Liver function test abnormal—Sibutramine—obesity	0.00062	0.00374	CcSEcCtD
Nevirapine—Anaphylactic shock—Cimetidine—obesity	0.000618	0.00373	CcSEcCtD
Nevirapine—Thrombocytopenia—Cimetidine—obesity	0.000605	0.00365	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Sibutramine—obesity	0.000605	0.00365	CcSEcCtD
Nevirapine—Nausea—Benzphetamine—obesity	0.000595	0.00359	CcSEcCtD
Nevirapine—Urticaria—Phentermine—obesity	0.000593	0.00358	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Sibutramine—obesity	0.000592	0.00358	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Diethylpropion—obesity	0.000591	0.00357	CcSEcCtD
Nevirapine—Abdominal pain—Phentermine—obesity	0.00059	0.00356	CcSEcCtD
Nevirapine—Pancreatitis—Orlistat—obesity	0.000588	0.00355	CcSEcCtD
Nevirapine—Somnolence—Diethylpropion—obesity	0.000577	0.00349	CcSEcCtD
Nevirapine—Eosinophilia—Sibutramine—obesity	0.000575	0.00347	CcSEcCtD
Nevirapine—Hypersensitivity—Phenylpropanolamine—obesity	0.000574	0.00347	CcSEcCtD
Nevirapine—Headache—Phendimetrazine—obesity	0.000572	0.00345	CcSEcCtD
Nevirapine—Face oedema—Bupropion—obesity	0.000565	0.00341	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Cimetidine—obesity	0.000563	0.0034	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Diethylpropion—obesity	0.00056	0.00339	CcSEcCtD
Nevirapine—Drug interaction—Topiramate—obesity	0.000554	0.00335	CcSEcCtD
Nevirapine—Somnolence—Cimetidine—obesity	0.000549	0.00332	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Topiramate—obesity	0.000543	0.00328	CcSEcCtD
Nevirapine—Nausea—Phendimetrazine—obesity	0.000542	0.00328	CcSEcCtD
Nevirapine—Asthenia—Phentermine—obesity	0.000535	0.00323	CcSEcCtD
Nevirapine—Feeling abnormal—Diethylpropion—obesity	0.000535	0.00323	CcSEcCtD
Nevirapine—Fatigue—Cimetidine—obesity	0.000532	0.00322	CcSEcCtD
Nevirapine—Renal failure—Orlistat—obesity	0.000526	0.00318	CcSEcCtD
Nevirapine—Neuropathy peripheral—Orlistat—obesity	0.000524	0.00317	CcSEcCtD
Nevirapine—Hyperglycaemia—Sibutramine—obesity	0.000523	0.00316	CcSEcCtD
Nevirapine—Urticaria—Diethylpropion—obesity	0.000516	0.00312	CcSEcCtD
Nevirapine—Diarrhoea—Phentermine—obesity	0.000511	0.00308	CcSEcCtD
Nevirapine—Feeling abnormal—Cimetidine—obesity	0.000509	0.00307	CcSEcCtD
Nevirapine—Renal failure—Sibutramine—obesity	0.000509	0.00307	CcSEcCtD
Nevirapine—Neuropathy peripheral—Sibutramine—obesity	0.000507	0.00306	CcSEcCtD
Nevirapine—Hepatobiliary disease—Orlistat—obesity	0.000506	0.00305	CcSEcCtD
Nevirapine—Conjunctivitis—Sibutramine—obesity	0.000503	0.00304	CcSEcCtD
Nevirapine—Pancreatitis—Bupropion—obesity	0.000496	0.003	CcSEcCtD
Nevirapine—Vomiting—Phenylpropanolamine—obesity	0.000496	0.003	CcSEcCtD
Nevirapine—Rash—Phenylpropanolamine—obesity	0.000492	0.00297	CcSEcCtD
Nevirapine—Dermatitis—Phenylpropanolamine—obesity	0.000491	0.00297	CcSEcCtD
Nevirapine—Body temperature increased—Cimetidine—obesity	0.000488	0.00295	CcSEcCtD
Nevirapine—Hepatitis—Orlistat—obesity	0.00048	0.0029	CcSEcCtD
Nevirapine—Vomiting—Phentermine—obesity	0.000474	0.00287	CcSEcCtD
Nevirapine—Rash—Phentermine—obesity	0.00047	0.00284	CcSEcCtD
Nevirapine—Dermatitis—Phentermine—obesity	0.00047	0.00284	CcSEcCtD
Nevirapine—Headache—Phentermine—obesity	0.000467	0.00282	CcSEcCtD
Nevirapine—Rash maculo-papular—Topiramate—obesity	0.000467	0.00282	CcSEcCtD
Nevirapine—Mouth ulceration—Topiramate—obesity	0.000464	0.00281	CcSEcCtD
Nevirapine—Nausea—Phenylpropanolamine—obesity	0.000463	0.0028	CcSEcCtD
Nevirapine—Hyperglycaemia—Bupropion—obesity	0.000456	0.00276	CcSEcCtD
Nevirapine—Hypersensitivity—Cimetidine—obesity	0.000455	0.00275	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Bupropion—obesity	0.000447	0.0027	CcSEcCtD
Nevirapine—Diarrhoea—Diethylpropion—obesity	0.000444	0.00268	CcSEcCtD
Nevirapine—Nausea—Phentermine—obesity	0.000443	0.00268	CcSEcCtD
Nevirapine—Asthenia—Cimetidine—obesity	0.000443	0.00268	CcSEcCtD
Nevirapine—Neuropathy peripheral—Bupropion—obesity	0.000442	0.00267	CcSEcCtD
Nevirapine—Jaundice—Bupropion—obesity	0.00044	0.00266	CcSEcCtD
Nevirapine—Conjunctivitis—Bupropion—obesity	0.000438	0.00265	CcSEcCtD
Nevirapine—Lymphadenopathy—Topiramate—obesity	0.000437	0.00264	CcSEcCtD
Nevirapine—Immune system disorder—Orlistat—obesity	0.000434	0.00262	CcSEcCtD
Nevirapine—Diarrhoea—Cimetidine—obesity	0.000423	0.00255	CcSEcCtD
Nevirapine—Immune system disorder—Sibutramine—obesity	0.00042	0.00253	CcSEcCtD
Nevirapine—Hepatic failure—Topiramate—obesity	0.000415	0.00251	CcSEcCtD
Nevirapine—Vomiting—Diethylpropion—obesity	0.000413	0.00249	CcSEcCtD
Nevirapine—Rash—Diethylpropion—obesity	0.000409	0.00247	CcSEcCtD
Nevirapine—Dermatitis—Diethylpropion—obesity	0.000409	0.00247	CcSEcCtD
Nevirapine—Headache—Diethylpropion—obesity	0.000407	0.00246	CcSEcCtD
Nevirapine—Hepatitis—Bupropion—obesity	0.000405	0.00245	CcSEcCtD
Nevirapine—Connective tissue disorder—Bupropion—obesity	0.000398	0.0024	CcSEcCtD
Nevirapine—Vomiting—Cimetidine—obesity	0.000393	0.00237	CcSEcCtD
Nevirapine—Rash—Cimetidine—obesity	0.000389	0.00235	CcSEcCtD
Nevirapine—Dermatitis—Cimetidine—obesity	0.000389	0.00235	CcSEcCtD
Nevirapine—Ill-defined disorder—Orlistat—obesity	0.000388	0.00234	CcSEcCtD
Nevirapine—Headache—Cimetidine—obesity	0.000387	0.00234	CcSEcCtD
Nevirapine—Nausea—Diethylpropion—obesity	0.000386	0.00233	CcSEcCtD
Nevirapine—Erythema multiforme—Bupropion—obesity	0.000383	0.00231	CcSEcCtD
Nevirapine—Angioedema—Orlistat—obesity	0.000382	0.00231	CcSEcCtD
Nevirapine—Malaise—Orlistat—obesity	0.000377	0.00228	CcSEcCtD
Nevirapine—Ill-defined disorder—Sibutramine—obesity	0.000375	0.00227	CcSEcCtD
Nevirapine—Anaemia—Sibutramine—obesity	0.000374	0.00226	CcSEcCtD
Nevirapine—Angioedema—Sibutramine—obesity	0.000369	0.00223	CcSEcCtD
Nevirapine—Nausea—Cimetidine—obesity	0.000367	0.00222	CcSEcCtD
Nevirapine—Immune system disorder—Bupropion—obesity	0.000366	0.00221	CcSEcCtD
Nevirapine—Malaise—Sibutramine—obesity	0.000365	0.0022	CcSEcCtD
Nevirapine—Face oedema—Topiramate—obesity	0.00036	0.00218	CcSEcCtD
Nevirapine—Myalgia—Orlistat—obesity	0.000356	0.00215	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000353	0.00213	CcSEcCtD
Nevirapine—Discomfort—Orlistat—obesity	0.000351	0.00212	CcSEcCtD
Nevirapine—Liver function test abnormal—Topiramate—obesity	0.000344	0.00208	CcSEcCtD
Nevirapine—Myalgia—Sibutramine—obesity	0.000344	0.00208	CcSEcCtD
Nevirapine—Arthralgia—Sibutramine—obesity	0.000344	0.00208	CcSEcCtD
Nevirapine—Anaphylactic shock—Orlistat—obesity	0.000341	0.00206	CcSEcCtD
Nevirapine—Oedema—Orlistat—obesity	0.000341	0.00206	CcSEcCtD
Nevirapine—Discomfort—Sibutramine—obesity	0.00034	0.00205	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Topiramate—obesity	0.000336	0.00203	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Topiramate—obesity	0.000336	0.00203	CcSEcCtD
Nevirapine—Nervous system disorder—Orlistat—obesity	0.000334	0.00202	CcSEcCtD
Nevirapine—Skin disorder—Orlistat—obesity	0.000331	0.002	CcSEcCtD
Nevirapine—Oedema—Sibutramine—obesity	0.00033	0.00199	CcSEcCtD
Nevirapine—Anaphylactic shock—Sibutramine—obesity	0.00033	0.00199	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Topiramate—obesity	0.000329	0.00199	CcSEcCtD
Nevirapine—Ill-defined disorder—Bupropion—obesity	0.000327	0.00198	CcSEcCtD
Nevirapine—Anaemia—Bupropion—obesity	0.000326	0.00197	CcSEcCtD
Nevirapine—Thrombocytopenia—Sibutramine—obesity	0.000323	0.00195	CcSEcCtD
Nevirapine—Angioedema—Bupropion—obesity	0.000322	0.00195	CcSEcCtD
Nevirapine—Skin disorder—Sibutramine—obesity	0.000321	0.00194	CcSEcCtD
Nevirapine—Eosinophilia—Topiramate—obesity	0.000319	0.00193	CcSEcCtD
Nevirapine—Malaise—Bupropion—obesity	0.000318	0.00192	CcSEcCtD
Nevirapine—Pancreatitis—Topiramate—obesity	0.000316	0.00191	CcSEcCtD
Nevirapine—Anorexia—Sibutramine—obesity	0.000315	0.0019	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Orlistat—obesity	0.000311	0.00188	CcSEcCtD
Nevirapine—Paraesthesia—Orlistat—obesity	0.000306	0.00185	CcSEcCtD
Nevirapine—Neutropenia—Topiramate—obesity	0.000301	0.00182	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Sibutramine—obesity	0.000301	0.00182	CcSEcCtD
Nevirapine—Myalgia—Bupropion—obesity	0.0003	0.00181	CcSEcCtD
Nevirapine—Arthralgia—Bupropion—obesity	0.0003	0.00181	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000298	0.0018	CcSEcCtD
Nevirapine—Discomfort—Bupropion—obesity	0.000297	0.00179	CcSEcCtD
Nevirapine—Decreased appetite—Orlistat—obesity	0.000296	0.00179	CcSEcCtD
Nevirapine—Paraesthesia—Sibutramine—obesity	0.000296	0.00179	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Orlistat—obesity	0.000294	0.00178	CcSEcCtD
Nevirapine—Fatigue—Orlistat—obesity	0.000294	0.00178	CcSEcCtD
Nevirapine—Somnolence—Sibutramine—obesity	0.000293	0.00177	CcSEcCtD
Nevirapine—Pain—Orlistat—obesity	0.000292	0.00176	CcSEcCtD
Nevirapine—Hyperglycaemia—Topiramate—obesity	0.000291	0.00176	CcSEcCtD
Nevirapine—Oedema—Bupropion—obesity	0.000288	0.00174	CcSEcCtD
Nevirapine—Anaphylactic shock—Bupropion—obesity	0.000288	0.00174	CcSEcCtD
Nevirapine—Decreased appetite—Sibutramine—obesity	0.000287	0.00173	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Topiramate—obesity	0.000285	0.00172	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Sibutramine—obesity	0.000285	0.00172	CcSEcCtD
Nevirapine—Renal failure—Topiramate—obesity	0.000282	0.00171	CcSEcCtD
Nevirapine—Pain—Sibutramine—obesity	0.000282	0.0017	CcSEcCtD
Nevirapine—Nervous system disorder—Bupropion—obesity	0.000282	0.0017	CcSEcCtD
Nevirapine—Neuropathy peripheral—Topiramate—obesity	0.000282	0.0017	CcSEcCtD
Nevirapine—Thrombocytopenia—Bupropion—obesity	0.000282	0.0017	CcSEcCtD
Nevirapine—Feeling abnormal—Orlistat—obesity	0.000281	0.0017	CcSEcCtD
Nevirapine—Skin disorder—Bupropion—obesity	0.000279	0.00169	CcSEcCtD
Nevirapine—Conjunctivitis—Topiramate—obesity	0.000279	0.00169	CcSEcCtD
Nevirapine—Gastrointestinal pain—Orlistat—obesity	0.000279	0.00168	CcSEcCtD
Nevirapine—Anorexia—Bupropion—obesity	0.000274	0.00166	CcSEcCtD
Nevirapine—Feeling abnormal—Sibutramine—obesity	0.000272	0.00164	CcSEcCtD
Nevirapine—Urticaria—Orlistat—obesity	0.000271	0.00164	CcSEcCtD
Nevirapine—Gastrointestinal pain—Sibutramine—obesity	0.00027	0.00163	CcSEcCtD
Nevirapine—Body temperature increased—Orlistat—obesity	0.00027	0.00163	CcSEcCtD
Nevirapine—Abdominal pain—Orlistat—obesity	0.00027	0.00163	CcSEcCtD
Nevirapine—Agranulocytosis—Topiramate—obesity	0.000268	0.00162	CcSEcCtD
Nevirapine—Urticaria—Sibutramine—obesity	0.000262	0.00158	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Bupropion—obesity	0.000262	0.00158	CcSEcCtD
Nevirapine—Body temperature increased—Sibutramine—obesity	0.000261	0.00158	CcSEcCtD
Nevirapine—Abdominal pain—Sibutramine—obesity	0.000261	0.00158	CcSEcCtD
Nevirapine—Paraesthesia—Bupropion—obesity	0.000258	0.00156	CcSEcCtD
Nevirapine—Hepatitis—Topiramate—obesity	0.000258	0.00156	CcSEcCtD
Nevirapine—Somnolence—Bupropion—obesity	0.000256	0.00155	CcSEcCtD
Nevirapine—Connective tissue disorder—Topiramate—obesity	0.000254	0.00153	CcSEcCtD
Nevirapine—Hypersensitivity—Orlistat—obesity	0.000251	0.00152	CcSEcCtD
Nevirapine—Decreased appetite—Bupropion—obesity	0.00025	0.00151	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Bupropion—obesity	0.000248	0.0015	CcSEcCtD
Nevirapine—Fatigue—Bupropion—obesity	0.000248	0.0015	CcSEcCtD
Nevirapine—Pain—Bupropion—obesity	0.000246	0.00149	CcSEcCtD
Nevirapine—Asthenia—Orlistat—obesity	0.000245	0.00148	CcSEcCtD
Nevirapine—Erythema multiforme—Topiramate—obesity	0.000244	0.00147	CcSEcCtD
Nevirapine—Hypersensitivity—Sibutramine—obesity	0.000243	0.00147	CcSEcCtD
Nevirapine—Pruritus—Orlistat—obesity	0.000241	0.00146	CcSEcCtD
Nevirapine—Feeling abnormal—Bupropion—obesity	0.000237	0.00143	CcSEcCtD
Nevirapine—Asthenia—Sibutramine—obesity	0.000237	0.00143	CcSEcCtD
Nevirapine—Gastrointestinal pain—Bupropion—obesity	0.000235	0.00142	CcSEcCtD
Nevirapine—Pruritus—Sibutramine—obesity	0.000233	0.00141	CcSEcCtD
Nevirapine—Diarrhoea—Orlistat—obesity	0.000233	0.00141	CcSEcCtD
Nevirapine—Immune system disorder—Topiramate—obesity	0.000233	0.00141	CcSEcCtD
Nevirapine—Urticaria—Bupropion—obesity	0.000229	0.00138	CcSEcCtD
Nevirapine—Abdominal pain—Bupropion—obesity	0.000227	0.00137	CcSEcCtD
Nevirapine—Body temperature increased—Bupropion—obesity	0.000227	0.00137	CcSEcCtD
Nevirapine—Diarrhoea—Sibutramine—obesity	0.000226	0.00136	CcSEcCtD
Nevirapine—Erythema—Topiramate—obesity	0.000225	0.00136	CcSEcCtD
Nevirapine—Vomiting—Orlistat—obesity	0.000217	0.00131	CcSEcCtD
Nevirapine—Rash—Orlistat—obesity	0.000215	0.0013	CcSEcCtD
Nevirapine—Dermatitis—Orlistat—obesity	0.000215	0.0013	CcSEcCtD
Nevirapine—Headache—Orlistat—obesity	0.000214	0.00129	CcSEcCtD
Nevirapine—Hypersensitivity—Bupropion—obesity	0.000212	0.00128	CcSEcCtD
Nevirapine—Vomiting—Sibutramine—obesity	0.00021	0.00127	CcSEcCtD
Nevirapine—Ill-defined disorder—Topiramate—obesity	0.000208	0.00126	CcSEcCtD
Nevirapine—Rash—Sibutramine—obesity	0.000208	0.00126	CcSEcCtD
Nevirapine—Dermatitis—Sibutramine—obesity	0.000208	0.00126	CcSEcCtD
Nevirapine—Anaemia—Topiramate—obesity	0.000208	0.00125	CcSEcCtD
Nevirapine—Headache—Sibutramine—obesity	0.000207	0.00125	CcSEcCtD
Nevirapine—Asthenia—Bupropion—obesity	0.000206	0.00125	CcSEcCtD
Nevirapine—Pruritus—Bupropion—obesity	0.000204	0.00123	CcSEcCtD
Nevirapine—Nausea—Orlistat—obesity	0.000203	0.00122	CcSEcCtD
Nevirapine—Malaise—Topiramate—obesity	0.000203	0.00122	CcSEcCtD
Nevirapine—Diarrhoea—Bupropion—obesity	0.000197	0.00119	CcSEcCtD
Nevirapine—Nausea—Sibutramine—obesity	0.000196	0.00118	CcSEcCtD
Nevirapine—Myalgia—Topiramate—obesity	0.000191	0.00116	CcSEcCtD
Nevirapine—Arthralgia—Topiramate—obesity	0.000191	0.00116	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00019	0.00115	CcSEcCtD
Nevirapine—Discomfort—Topiramate—obesity	0.000189	0.00114	CcSEcCtD
Nevirapine—Oedema—Topiramate—obesity	0.000183	0.00111	CcSEcCtD
Nevirapine—Vomiting—Bupropion—obesity	0.000183	0.00111	CcSEcCtD
Nevirapine—Rash—Bupropion—obesity	0.000181	0.0011	CcSEcCtD
Nevirapine—Dermatitis—Bupropion—obesity	0.000181	0.00109	CcSEcCtD
Nevirapine—Headache—Bupropion—obesity	0.00018	0.00109	CcSEcCtD
Nevirapine—Nervous system disorder—Topiramate—obesity	0.00018	0.00109	CcSEcCtD
Nevirapine—Thrombocytopenia—Topiramate—obesity	0.000179	0.00108	CcSEcCtD
Nevirapine—Skin disorder—Topiramate—obesity	0.000178	0.00108	CcSEcCtD
Nevirapine—Anorexia—Topiramate—obesity	0.000175	0.00106	CcSEcCtD
Nevirapine—Nausea—Bupropion—obesity	0.000171	0.00103	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Topiramate—obesity	0.000167	0.00101	CcSEcCtD
Nevirapine—Paraesthesia—Topiramate—obesity	0.000165	0.000994	CcSEcCtD
Nevirapine—Somnolence—Topiramate—obesity	0.000163	0.000984	CcSEcCtD
Nevirapine—Decreased appetite—Topiramate—obesity	0.000159	0.000963	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Topiramate—obesity	0.000158	0.000956	CcSEcCtD
Nevirapine—Fatigue—Topiramate—obesity	0.000158	0.000955	CcSEcCtD
Nevirapine—Pain—Topiramate—obesity	0.000157	0.000947	CcSEcCtD
Nevirapine—Feeling abnormal—Topiramate—obesity	0.000151	0.000912	CcSEcCtD
Nevirapine—Gastrointestinal pain—Topiramate—obesity	0.00015	0.000905	CcSEcCtD
Nevirapine—Urticaria—Topiramate—obesity	0.000146	0.00088	CcSEcCtD
Nevirapine—Abdominal pain—Topiramate—obesity	0.000145	0.000875	CcSEcCtD
Nevirapine—Body temperature increased—Topiramate—obesity	0.000145	0.000875	CcSEcCtD
Nevirapine—Hypersensitivity—Topiramate—obesity	0.000135	0.000816	CcSEcCtD
Nevirapine—Asthenia—Topiramate—obesity	0.000132	0.000794	CcSEcCtD
Nevirapine—Pruritus—Topiramate—obesity	0.00013	0.000783	CcSEcCtD
Nevirapine—Diarrhoea—Topiramate—obesity	0.000125	0.000758	CcSEcCtD
Nevirapine—Vomiting—Topiramate—obesity	0.000117	0.000704	CcSEcCtD
Nevirapine—Rash—Topiramate—obesity	0.000116	0.000698	CcSEcCtD
Nevirapine—Dermatitis—Topiramate—obesity	0.000115	0.000698	CcSEcCtD
Nevirapine—Headache—Topiramate—obesity	0.000115	0.000694	CcSEcCtD
Nevirapine—Nausea—Topiramate—obesity	0.000109	0.000658	CcSEcCtD
Nevirapine—CYP1A2—Metabolism—NAMPT—obesity	8.07e-06	9.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SREBF2—obesity	8.07e-06	9.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HK1—obesity	8.07e-06	9.16e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BCHE—obesity	8.05e-06	9.14e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	8.03e-06	9.11e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LIPC—obesity	8.02e-06	9.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GCK—obesity	8.02e-06	9.1e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—FASN—obesity	8.02e-06	9.1e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BCHE—obesity	7.98e-06	9.06e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOC3—obesity	7.97e-06	9.05e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPX1—obesity	7.93e-06	9e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	7.92e-06	8.98e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CD36—obesity	7.9e-06	8.97e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—obesity	7.8e-06	8.85e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPA—obesity	7.8e-06	8.84e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2E1—obesity	7.77e-06	8.82e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CETP—obesity	7.74e-06	8.78e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CD36—obesity	7.72e-06	8.76e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2E1—obesity	7.7e-06	8.74e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NQO1—obesity	7.68e-06	8.72e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SDC1—obesity	7.65e-06	8.69e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPIN1—obesity	7.63e-06	8.66e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NQO1—obesity	7.62e-06	8.64e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKR1C3—obesity	7.53e-06	8.54e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—obesity	7.53e-06	8.54e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTHFR—obesity	7.49e-06	8.5e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA5—obesity	7.47e-06	8.48e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	7.46e-06	8.46e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—POMC—obesity	7.42e-06	8.42e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SCARB1—obesity	7.41e-06	8.41e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	7.39e-06	8.38e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—INS—obesity	7.38e-06	8.37e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC2A4—obesity	7.37e-06	8.36e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GCG—obesity	7.37e-06	8.36e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARA—obesity	7.35e-06	8.34e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTHFR—obesity	7.32e-06	8.3e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	7.31e-06	8.3e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC2A4—obesity	7.3e-06	8.29e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GCG—obesity	7.3e-06	8.29e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYCS—obesity	7.27e-06	8.25e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	7.22e-06	8.19e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYCS—obesity	7.21e-06	8.18e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SREBF1—obesity	7.2e-06	8.17e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARA—obesity	7.18e-06	8.15e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GGT1—obesity	7.13e-06	8.09e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GOT1—obesity	7.13e-06	8.09e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CLOCK—obesity	7.13e-06	8.09e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC22A1—obesity	7.13e-06	8.09e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AGT—obesity	7.11e-06	8.07e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GGT1—obesity	7.07e-06	8.02e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GOT1—obesity	7.07e-06	8.02e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOA1—obesity	7.03e-06	7.97e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT2—obesity	7e-06	7.94e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOE—obesity	6.97e-06	7.91e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOA1—obesity	6.97e-06	7.9e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AGT—obesity	6.95e-06	7.89e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SULT2A1—obesity	6.95e-06	7.88e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GLP1R—obesity	6.95e-06	7.88e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—STK11—obesity	6.93e-06	7.86e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP19A1—obesity	6.93e-06	7.86e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAV1—obesity	6.91e-06	7.84e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	6.9e-06	7.83e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—APOA1—obesity	6.89e-06	7.82e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP19A1—obesity	6.87e-06	7.79e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—STK11—obesity	6.87e-06	7.79e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CD—obesity	6.85e-06	7.78e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—FASN—obesity	6.85e-06	7.77e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—DPYD—obesity	6.84e-06	7.76e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BCHE—obesity	6.82e-06	7.74e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOE—obesity	6.81e-06	7.73e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—obesity	6.77e-06	7.68e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAV1—obesity	6.75e-06	7.66e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—APOA1—obesity	6.74e-06	7.64e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2E1—obesity	6.58e-06	7.47e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PRKAR2B—obesity	6.58e-06	7.47e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—DCN—obesity	6.53e-06	7.41e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NQO1—obesity	6.51e-06	7.39e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3R1—obesity	6.47e-06	7.34e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NOS3—obesity	6.47e-06	7.34e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—COMT—obesity	6.44e-06	7.31e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—COMT—obesity	6.38e-06	7.24e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	6.37e-06	7.23e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CPT1A—obesity	6.35e-06	7.21e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARGC1A—obesity	6.35e-06	7.2e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GNB3—obesity	6.35e-06	7.2e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HMOX1—obesity	6.32e-06	7.17e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	6.32e-06	7.17e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GNB3—obesity	6.29e-06	7.14e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARGC1A—obesity	6.29e-06	7.14e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—obesity	6.29e-06	7.14e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HMOX1—obesity	6.27e-06	7.11e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC2A4—obesity	6.24e-06	7.08e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GCG—obesity	6.24e-06	7.08e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NAMPT—obesity	6.23e-06	7.07e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LIPC—obesity	6.19e-06	7.03e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCK—obesity	6.19e-06	7.03e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GNAS—obesity	6.18e-06	7.01e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYCS—obesity	6.16e-06	6.99e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOC3—obesity	6.15e-06	6.98e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—obesity	6.15e-06	6.98e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GNAS—obesity	6.13e-06	6.95e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—obesity	6.07e-06	6.89e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOB—obesity	6.05e-06	6.87e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GGT1—obesity	6.04e-06	6.86e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GOT1—obesity	6.04e-06	6.86e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOB—obesity	6e-06	6.81e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—POMC—obesity	5.99e-06	6.79e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CETP—obesity	5.97e-06	6.78e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CB—obesity	5.97e-06	6.78e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—INS—obesity	5.96e-06	6.76e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOA1—obesity	5.95e-06	6.75e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—obesity	5.93e-06	6.73e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—obesity	5.92e-06	6.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SDC1—obesity	5.91e-06	6.7e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—STK11—obesity	5.87e-06	6.66e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP19A1—obesity	5.87e-06	6.66e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—POMC—obesity	5.85e-06	6.64e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—INS—obesity	5.82e-06	6.6e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKR1C3—obesity	5.81e-06	6.59e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LPL—obesity	5.78e-06	6.56e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LPL—obesity	5.73e-06	6.5e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SCARB1—obesity	5.72e-06	6.49e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPX1—obesity	5.64e-06	6.4e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPX1—obesity	5.59e-06	6.34e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SREBF1—obesity	5.55e-06	6.3e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CD—obesity	5.53e-06	6.28e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CD36—obesity	5.49e-06	6.23e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—obesity	5.46e-06	6.19e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—COMT—obesity	5.45e-06	6.19e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CD36—obesity	5.44e-06	6.18e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CD—obesity	5.41e-06	6.13e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT2—obesity	5.4e-06	6.13e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GNB3—obesity	5.38e-06	6.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARGC1A—obesity	5.38e-06	6.1e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HMOX1—obesity	5.35e-06	6.07e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—obesity	5.34e-06	6.05e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—FASN—obesity	5.29e-06	6e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BCHE—obesity	5.27e-06	5.97e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GNAS—obesity	5.24e-06	5.94e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3R1—obesity	5.22e-06	5.93e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NOS3—obesity	5.22e-06	5.93e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTHFR—obesity	5.2e-06	5.9e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTHFR—obesity	5.16e-06	5.85e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOB—obesity	5.13e-06	5.82e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARA—obesity	5.11e-06	5.79e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3R1—obesity	5.1e-06	5.79e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NOS3—obesity	5.1e-06	5.79e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2E1—obesity	5.08e-06	5.76e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARA—obesity	5.06e-06	5.74e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NQO1—obesity	5.02e-06	5.7e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AGT—obesity	4.94e-06	5.61e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AGT—obesity	4.9e-06	5.56e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LPL—obesity	4.9e-06	5.56e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOE—obesity	4.85e-06	5.5e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CB—obesity	4.82e-06	5.47e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GCG—obesity	4.82e-06	5.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC2A4—obesity	4.82e-06	5.46e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOE—obesity	4.8e-06	5.45e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAV1—obesity	4.8e-06	5.45e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—APOA1—obesity	4.79e-06	5.43e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPX1—obesity	4.78e-06	5.42e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—obesity	4.78e-06	5.42e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAV1—obesity	4.76e-06	5.4e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYCS—obesity	4.75e-06	5.39e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—APOA1—obesity	4.75e-06	5.39e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CB—obesity	4.71e-06	5.35e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—obesity	4.67e-06	5.3e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GGT1—obesity	4.66e-06	5.29e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GOT1—obesity	4.66e-06	5.29e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CD36—obesity	4.65e-06	5.28e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOA1—obesity	4.59e-06	5.21e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.55e-06	5.16e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—STK11—obesity	4.53e-06	5.14e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP19A1—obesity	4.53e-06	5.14e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTHFR—obesity	4.41e-06	5e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—obesity	4.37e-06	4.96e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—obesity	4.33e-06	4.92e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARA—obesity	4.33e-06	4.91e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—obesity	4.22e-06	4.79e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—COMT—obesity	4.21e-06	4.78e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AGT—obesity	4.19e-06	4.75e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—obesity	4.18e-06	4.75e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—POMC—obesity	4.16e-06	4.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GNB3—obesity	4.15e-06	4.71e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARGC1A—obesity	4.15e-06	4.71e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—INS—obesity	4.14e-06	4.7e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HMOX1—obesity	4.13e-06	4.69e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—POMC—obesity	4.13e-06	4.68e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOE—obesity	4.1e-06	4.66e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—INS—obesity	4.1e-06	4.66e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAV1—obesity	4.07e-06	4.61e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—APOA1—obesity	4.06e-06	4.6e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GNAS—obesity	4.04e-06	4.59e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOB—obesity	3.96e-06	4.49e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.89e-06	4.41e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CD—obesity	3.84e-06	4.36e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CD—obesity	3.81e-06	4.32e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—obesity	3.79e-06	4.31e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LPL—obesity	3.78e-06	4.29e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—obesity	3.76e-06	4.27e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—obesity	3.7e-06	4.2e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX1—obesity	3.69e-06	4.18e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—obesity	3.64e-06	4.13e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3R1—obesity	3.63e-06	4.12e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NOS3—obesity	3.63e-06	4.12e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3R1—obesity	3.6e-06	4.08e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NOS3—obesity	3.6e-06	4.08e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CD36—obesity	3.59e-06	4.07e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—obesity	3.58e-06	4.06e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—POMC—obesity	3.53e-06	4e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—INS—obesity	3.51e-06	3.98e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTHFR—obesity	3.4e-06	3.86e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CB—obesity	3.35e-06	3.8e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARA—obesity	3.34e-06	3.79e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CB—obesity	3.32e-06	3.77e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—obesity	3.32e-06	3.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—obesity	3.29e-06	3.73e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CD—obesity	3.26e-06	3.69e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AGT—obesity	3.23e-06	3.67e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—obesity	3.21e-06	3.65e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOE—obesity	3.17e-06	3.59e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAV1—obesity	3.14e-06	3.56e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—APOA1—obesity	3.13e-06	3.55e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NOS3—obesity	3.07e-06	3.49e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3R1—obesity	3.07e-06	3.49e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—obesity	2.98e-06	3.38e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—obesity	2.94e-06	3.33e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—obesity	2.87e-06	3.26e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—obesity	2.86e-06	3.24e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CB—obesity	2.84e-06	3.22e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—obesity	2.81e-06	3.19e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—obesity	2.76e-06	3.13e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—POMC—obesity	2.72e-06	3.09e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—INS—obesity	2.71e-06	3.07e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CD—obesity	2.51e-06	2.85e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—obesity	2.48e-06	2.81e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—obesity	2.4e-06	2.72e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NOS3—obesity	2.37e-06	2.69e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3R1—obesity	2.37e-06	2.69e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—obesity	2.35e-06	2.66e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CB—obesity	2.19e-06	2.49e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—obesity	2.17e-06	2.46e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—obesity	2.04e-06	2.32e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—obesity	2.02e-06	2.3e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—obesity	1.73e-06	1.96e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—obesity	1.67e-06	1.89e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—obesity	1.65e-06	1.88e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—obesity	1.41e-06	1.6e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—obesity	1.34e-06	1.52e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—obesity	1.09e-06	1.24e-05	CbGpPWpGaD
